These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24183420)

  • 1. Re: JinQiu Yuan, RenJie Zhang, ZuYao Yang, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol 2013;63:902-12.
    Jiann BP
    Eur Urol; 2014 Mar; 65(3):e40. PubMed ID: 24183420
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Seftel A
    J Urol; 2013 Oct; 190(4):1340. PubMed ID: 24029345
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Yuan J; Zhang R; Yang Z; Lee J; Liu Y; Tian J; Qin X; Ren Z; Ding H; Chen Q; Mao C; Tang J
    Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Erectile function, erection hardness and tolerability in men treated with sildenafil 100 mg vs. 50 mg for erectile dysfunction.
    Seftel AD
    J Urol; 2014 Apr; 191(4):1078. PubMed ID: 24703144
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer phosphodiesterase inhibitors: comparison with established agents.
    McNamara ER; Donatucci CF
    Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17 years of clinical experience with phosphodiesterase type 5 inhibitors: what do we have yet to learn?
    Verze P; Cai T; Palmieri A; Mirone V
    Eur Urol; 2015 Oct; 68(4):681-2. PubMed ID: 25887787
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply from authors re: Arthur L. Burnett. Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy. Eur Urol 2014;65:597-8: although erection rehabilitation after prostatectomy remains indefinite, the most effective treatment, the earliest recovery, and the preservation of erectile function remain a definite goal.
    Brock G; Montorsi F; Büttner H; Henneges C; Mulhall J
    Eur Urol; 2014 Mar; 65(3):598-9. PubMed ID: 24287317
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Efficacy of Once-Daily Administration of Udenafil for 24 Weeks on Erectile Dysfunction: Results from a Randomized Multicenter Placebo-Controlled Clinical Trial.
    Seftel AD
    J Urol; 2015 Aug; 194(2):495. PubMed ID: 26195408
    [No Abstract]   [Full Text] [Related]  

  • 9. A broad-spectrum approach to daily tadalafil: making the big picture even bigger.
    Verze P; Arcaniolo D; La Rocca R; Mirone V
    Eur Urol; 2014 Feb; 65(2):465-6. PubMed ID: 24563912
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
    Li J; Shi Q; Wei Q; Han P
    Aging Male; 2015 Jun; 18(2):71. PubMed ID: 25162329
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities].
    Puigvert AM; Prieto R; García F
    Rev Int Androl; 2018; 16(1):28-33. PubMed ID: 30063020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis.
    Chen L; Staubli SE; Schneider MP; Kessels AG; Ivic S; Bachmann LM; Kessler TM
    Eur Urol; 2015 Oct; 68(4):674-80. PubMed ID: 25817916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses.
    Peng Z; Yang L; Dong Q; Wei Q; Liu L; Yang B
    Urol Int; 2017; 99(3):343-352. PubMed ID: 28628914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of phosphodiesterase type 5 inhibitors on penile rigidity variables during a period with no sexual stimulation: a laboratory setting double-blind study.
    Gökçe A; Demirtas A; Halis F; Ekmekcioglu O
    BJU Int; 2011 Jan; 107(2):264-7. PubMed ID: 20438562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.
    Kaiho Y; Yamashita S; Arai Y
    Int J Urol; 2013 Mar; 20(3):285-9. PubMed ID: 23311962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
    Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
    Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on "Efficacy and safety of oral phosphodiesterase 5 inhibitor for erectile dysfunction: a network meta-analysis and multicriteria decision".
    Ranjan KR; Sharma G
    World J Urol; 2021 Jul; 39(7):2815-2816. PubMed ID: 32474824
    [No Abstract]   [Full Text] [Related]  

  • 18. Simplified Interpretation of the Erectile Function Domain of the International Index of Erectile Function.
    Cappelleri JC; Tseng LJ; Luo X; Stecher V; Lue TF
    J Sex Med; 2016 Apr; 13(4):690-6. PubMed ID: 26936074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy.
    Burnett AL
    Eur Urol; 2014 Mar; 65(3):597-8. PubMed ID: 24268502
    [No Abstract]   [Full Text] [Related]  

  • 20. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.